they rename lncRNA in the NHEJ pathway 1 (LINP1)-enhances doxorubicin-induced cell death in TNBC cell lines. Like ionizing radiation (IR), doxorubicin treatment induces DNA double-strand breaks (DSBs), the most toxic form of DNA damage. In human cells, DSBs are mainly repaired by the NHEJ pathway. Thus, these studies suggest that the major pathway for the repair of DNA DSBs in human cells may be regulated by the lncRNA LINP1, whose dysregulation might promote therapeutic resistance in TNBC 2 .
NHEJ is initiated when a DNA DSB is detected and bound by the Ku70-Ku80 hetero dimer (Fig. 1) . Ku then recruits additional NHEJ proteins to the DSBs, which process and subsequently ligate the broken DNA ends 6 . One well-characterized Ku-interacting protein is the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a serine/threonine protein kinase that is essential for NHEJ in human cells 7 . Zhang et al. 2 have demonstrated that LINP1 interacts with and enhances formation of the Ku-DNA-PKcs complex. Moreover, cells acts as a scaffold that promotes DNA repair, thus promoting resistance to radiation and chemotherapeutic drugs in TNBC cells. The exciting finding that RNA molecules can directly regulate DNA-repair pathways offers possibilities for new therapeutic approaches for TNBC.
Less than 2% of the human genome comprises protein-coding genes, whereas ~70% of the genome is transcribed into thousands of noncoding RNAs 3 . Among these are ~16,000 lncRNAs, defined as >200-base transcripts that have no apparent protein-coding function 4 . lncRNAs form complex secondary structures and are highly regulated. Through their ability to bind proteins and nucleic acids, lncNRAs can modulate protein-protein and protein-nucleic acid interactions that control many cellular processes. Indeed, lncRNAs are emerging as key players in human disease, including cancer 5 . Zhang et al. 2 have identified over 100 lncRNAs that are enriched in TNBC and have found that depletion of one, the lncRNA ENSG00000223784-which The American Cancer Society forecasted over 230,000 new cases of invasive breast cancer in 2015, of which ~12% were predicted to be triple-negative breast cancer (TNBC), owing to loss of expression of estrogen and progesterone receptors and human epidermal growth factor type II receptor (HER2). TNBC is an aggressive form of breast cancer with a relatively poor short-term prognosis, in part because there are no targeted therapies 1 . In this issue, Zhang et al. 2 provide evidence that a long noncoding RNA (lncRNA) molecule that is highly expressed in TNBC importantly, the new work extends previously recognized parallels between the group II intron and spliceosomal RNA structures to include not only the structures of central protein cofactors but also the interactions between these cofactors and catalytic RNA (Fig. 3) . As such, the structures illuminate the final piece of an evolutionary puzzle and define an ancestral RNP from which group II introns and the spliceosome have evolved. Indeed, the work supports the views that spliceosomal small nuclear RNAs are derived from the fragmentation 20 of an ancient group II intron ribozyme, and that a central RT cofactor coevolved to maintain splicing activity, while retrohoming activities degenerated.
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The author declares no competing financial interests. In this regard, the cryo-EM structure reveals that the RT and endonuclease catalytic cores are 45 Å away from each other and thus would require a substantial conformational rearrangement of LtrA or the RNA-DNA substrate to initiate reverse transcription at the site of DNA cleavage. Interestingly, dimerization of LtrA according to the R.i. RT structure juxtaposes the RT and endonuclease domains, thus hinting that the dimer may function at the stage of reverse transcription. Together, these two landmark studies 5, 6 raise new questions and establish a structural framework that is certain to inspire in-depth mechanistic studies of group II intron splicing and retrohoming. Furthermore, given the strong sequence similarity between group II intron RTs and the structurally uncharacterized RTs of non-LTR retroelements, the structures of the group II intron RT shed new light on these ubiquitous elements that have sculpted over 15% of the human genome. Perhaps most Noncoding RNA joins Ku and DNA-PKcs for DNA-break resistance in breast cancer whereas wild-type p53 decreases LINP1 expression through a miR-29-dependent pathway. Because p53 is frequently mutated in TNBC, dual regulation of LINP1 by overactivation of EGFR signaling combined with a loss of downregulation by p53 may enhance NHEJ and promote resistance to IR and chemotherapy 2 . Furthermore, because LINP1 links Ku and DNA-PKcs, which jointly initiate NHEJ, modulating LINP1 may provide an additional mechanism to control pathway choice in DSB repair. Inhibition of the MRE11 endonuclease, which licenses repair via homologous recombination, promotes a switch to NHEJ repair, thereby eliminating repair defects from BRCA2 mutations 8 . Targeting LINP1 expression may similarly enable a new therapeutic strategy in TNBC that can overcome the effects of defects in p53 and EGFR and the resultant LINP1 dysregulation.
The study by Zhang et al. 2 additionally raises interesting biological questions regarding the mechanisms of DSB repair. Whereas NHEJ is largely defined by its ability to detect and repair DSBs, Ku also interacts with RNA, specifically the telomerase-associated RNA component hTR 9, 10 , and this interaction may facilitate regulation of proteins involved in telomerelength maintenance 11 . Like LINP1, large segments of hTR are predicted to form stem-loops and double-stranded RNA elements, thus raising the possibility that Ku may interact directly with RNA secondary structures. The core DNA-binding region of Ku70-Ku80 contains a preformed ring domain that binds to ends of double-stranded DNA with high affinity and low sequence specificity 12 . However, Ku can also interact with circular single-stranded DNA 13, 14 , most probably through stem-loop structures. As mentioned above, the interaction of Ku with DNA promotes the recruitment of additional NHEJ proteins, including DNA-PKcs, which is flexibly linked to Ku80 via Ku80's C-terminal domain 15 . How LINP1 provides a scaffold to stabilize this interaction, and how this enhanced stability promotes NHEJ, remain to be determined. Other factors known to enhance NHEJ include aprataxin and polynucleotide kinase phosphatase like protein (APLF), which interacts with Ku80 and XRCC4 (ref. 16 ), thus suggesting that perhaps, like LINP1, APLF may also have a scaffolding role. Indeed, emerging data underscore the importance of scaffolding molecules in both homologous recombination and NHEJ. Consequently, both DSB-repair pathways are increasingly being viewed as dynamic interactive assemblies of multiprotein complexes rather than as linear pathways in which each protein leaves, depletion of LINP1 attenuates DSB repair, induces radiation sensitivity and, in mouse xenografts, delays tumor growth after exposure to IR. Together, their data reveal that the interaction of LINP1 with the Ku-DNA-PKcs complex enhances NHEJ-mediated DSB repair and that depleting LINP1 improves the response to IR in vitro and in vivo.
Zhang et al. 2 have also identified new links among epidermal growth factor signaling, p53 status and LINP1 that enhance the implications of these results for potential cancer therapy. Specifically, they report that epidermal growth factor receptor (EGFR), which is frequently amplified in TNBC, increases LINP1 expression through the Ras-MAP kinase pathway, and the next one takes its place 6, 17 . It will be exciting to elucidate how LINP1 and other potential DSB-repair scaffolds facilitate interactions required for regulation, end processing and ligation while helping to tether DNA ends. In addition, it will be interesting to determine whether LINP1 and NHEJ are involved in the translocations and deletion breakpoints associated with non-B-DNA-forming sequences in cancer genomes 18 .
The findings of Zhang et al. 2 may also be more broadly relevant to DNA-damageresponse mechanisms, because recent screens have revealed that over 50% of genes that induce endogenous DNA damage when suppressed are involved in RNA metabolism 19, 20 . Although recent research has focused largely on the roles of R loops in the DNA-damage response 21 , the present study 2 suggests that lncRNAs and other RNA molecules may be directly involved in regulating DNA repair, and their potential multifaceted effects in cancer and DNA-repair biology may open new avenues for research and possible therapeutic strategies. Ras/MAPK/Jun LINP1 n e w s a n d v i e w s npg
